Clinical-epidemiological characteristics and knowledge on american tegumentary leishmaniosis in a Carabobo state population. Venezuela

  • Karim Abdel Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela
  • Daniela Hernández Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela
  • Oniel Hidalgo Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela
  • Sol Hidalgo Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela
  • Cristina Lorenzo Departamento de Salud Pública, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela
  • Fernando Hung Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela
  • Gilberto A. Bastidas Departamento de Salud Pública, Facultad de Ciencias de la Salud, Universidad de Carabobo, Venezuela https://orcid.org/0000-0002-5805-6926
Keywords: Leishmaniosis, signs and symptoms, epidemiology, parasitosis, skin (Source: MeSH NLM)

Abstract

Of American tegumentary leishmaniasis 1.5 million new cases are registered, it is present in 88 countries, this makes it occupy the sixth place among the major diseases of the world and the second among parasitic diseases only behind malaria, but in Latin America they are The work on knowledge of American tegumentary leishmaniasis as support for health control programs is scarce, but the majority only focus on aspects such as: chemical and biological vector control, reservoir study, seroprevalence in endemic areas, pharmacological treatment and immunotherapy. The objective is to determine the clinical-epidemiological characteristics and knowledge about American tegumentary leishmaniasis. Descriptive study with documentary and field research design, based on the review of the epidemiological record and application of a questionnaire. The majority of those affected are young adults (20-59 years) (66.3%) of the male gender, workers (27.4%) with upper limb injuries (40.5%), generally unique (53.4%) and treated (86.3%). 80% know the disease and 83% know the transmitter, and 38% know the pharmacological treatment. It is concluded that those affected with LTA are mainly men, in economically productive age, workers and farmers, with educational levels not exceeding half diversified, located in relative poverty as socio-economic stratum, with unique skin lesions in exposed regions of the body and pharmacologically treated; that the population knows the natural history of the disease and the transmitter, but they are unaware of aspects of the biology of the insect; and who know and prefer the medical-pharmacological treatment of the medical-scientific system and the public curative service.

Downloads

Download data is not yet available.

References

Organización Mundial de la Salud. Centro de prensa Nota descriptiva. Citado agosto 2018. Disponible en:

http://www.who.int/mediacentre/factsheets/fs375/es/ 2016.

Chavy A, Ferreira Dales Nava A, Luz S, Ramírez J, Herrera G, Vasconcelos Dos Santos T, Ginouves M, Demar M, Prévot G, Guégan J, de Thoisy B. Ecological niche modelling for predicting the risk of cutaneous leishmaniasis in the Neotropical moist forest biome. PLoS Negl Trop Dis. 2019; 13(8):e0007629. (doi: 10.1371/journal.pntd.0007629).

Uribe-Restrepo A, Cossio A, Desai M, Dávalos D, Castro M. Interventions to treat cutaneous leishmaniasis in children: A systematic review. PLoS Negl Trop Dis. 2018; 12(12):e0006986. (doi: 10.1371/journal.pntd.0006986).

Feliciangeli M. Leishmaniosis en Venezuela: Situación actual, acciones y perspectivas para el control vectorial en el marco de un programa de control multisectorial, 2014. Bol Mal Salud Amb. 2014; 54(1):1-5.

Organización Mundial de la Salud. Informe de una reunión del Comité de Expertos de la OMS sobre el control de las leishmaniasis, Ginebra, 22-26 Mar 2010. Ser Inf Técn. 949.2010. Citado marzo 2018. Disponible en:

www.who.int/iris/bitstream/10665/82766/1/WHO_TRS_949_spa.pdf.

Organización Mundial de la Salud. 60ª Asamblea Mundial de la Salud. Control de la leishmaniasis. Informe de la Secretaria; Resolución N° A60/10; Ginebra, Suiza. 2007. Citado mayo 2018. Disponible en: apps.who.int/gb/ebwha/pdf_files/...WHA60-Rec1/.../WHASS1_WHA60REC1-sp.pdf.

Scorza J. Protocolo para la investigación epidemiológica de Leishmaniasis tegumentaria en Venezuela. Bol Mal Salud Amb. 1988; 28:83-90.

Ortega J, Zerpa O, Sosa A, Rodríguez N, Aranzazu N. Estudio Clínico, Epidemiológico y Caracterización Taxonómica de Leishmaniasis Cutánea en el Estado Vargas, Venezuela. Dermatol Venez. 2004; 42(4):10-16.

De Lima H, Borges R, Escobar J, Convit J. Leishmaniasis cutánea americana en Venezuela: un análisis clínico epidemiológico a nivel nacional y por entidad federal, 1988-2007. Bol Mal Salud Amb. 2010; 50(2):283-299.

Ministerio Poder Popular para la Salud. Boletín epidemiológico semana 52. Citado agosto 2018. Disponible en: http: www.mpps.gob.ve. 2015.

Buttigieg S. Innovation Strategies and Health System Guiding Principles to Address Equity and Sustainability in Responsible Innovation in Health Comment on "What Health System Challenges Should Responsible Innovation in Health Address? Insights From an International Scoping Review". Int J Health Policy Manag. 2019; 8(9):570-572. (doi: 10.15171/ijhpm.2019.50).

Mokni M. Cutaneous leishmaniasis. Ann Dermatol Venereol. 2019; 146(3):232-246. (doi: 10.1016/j.annder.2019.02.002).

Clifford J. Parcial truths: introduction. In: On Writing Culture: The Poetics and Politics of Ethnography (J. Clifford & G. Marcus, ed), pp.1-26, Berkeley: University of California Press.1986.

Testa M. Extensión de cobertura con atención médica primaria. Venezuela. Documentos CENDES-UCU, No. 14. 1981.

Bastidas G, Díaz B. Prácticas y conocimientos populares sobre leishmaniasis tegumentaria americana (LTA) en un área endémica de Cojedes, Venezuela. Hacia el desarrollo de estrategias educativas alternativas de control. Fermentum. 2008; 18(53):634-655.

Méndez C, López B, Landaeta J, Gónzales T. Estudio transversal de Caracas. Arch. Venez. Pueric. Pediatr. 1983; 49:111-155.

Barberino S, Lauand L, Santos G, De Oliveria M. Factores socio-económicos e atitudes em relacao a prevencao domiciliar da Leishmaniose Tegumentar Americana, em uma area endémica do Sul da Bahia, Brasil. Cad Saude Publica. 2000; 16(3):701-708.

García B. Aporte de la etnografía en el conocimiento de los códigos socioculturales de la leishmaniasis cutánea localizada en un programa de educación para la salud, en Venezuela. Cad Saude Publica. 2007; 23(Supl.1):S75-S83.

Teles G, Fonseca F, Gonçalves M. American Tegumentary Leishmaniasis in the Brazilian Amazon from 2010 to 2014. Rev Inst Med Trop Sao Paulo. 2019; 61:e22. (doi: 10.1590/S1678-9946201961022).

Vasconcelos-Dos-Santos T, Chaves R, Prévot G, Silveira F, Póvoa M, Rangel E. Binational burden of american cutaneous leishmaniasis in Oiapoque, Amapá State, Brazil, bordering French Guiana. Rev Soc Bras Med Trop. 2019; 52:e20180256. (doi: 10.1590/0037-8682-0256-2018).

Manotas-Berdugo H, Toro-Maldonado J, Rodríguez-Rodríguez J, Salgado-García D. Urban outbreak of leishmaniasis in Colombia. Rev Salud Publica (Bogota). 2018; 20(1):89-93. (doi: 10.15446/rsap.V20n1.47135).

Cohnstaedt L, Alfonso-Parra C. Highlights of Mosquito and Vector Biology and Control in Latin America. J Am Mosq Control Assoc. 2019; 35(1):40-46. (doi: 10.2987/18-6769.1).

Detoni M, Lima D, Silva T, Machado L, Tomiotto-Pellissier F, Costa I, Pavanelli W, Oliveira FA, Custódio L, Conchon-Costa I, Melanda F . Temporal and spatial distribution of American tegumentary leishmaniasis in north Paraná: 2010-2015. Rev Soc Bras Med Trop. 2019; 52:e20180119. (doi: 10.1590/0037-8682-0119-2018).

Sunyoto T, Boelaert M, Meheus F. Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic review. Expert Rev Anti Infect Ther. 2019; 17(1):57-69. (doi: 10.1080/14787210.2019.1555471).

dos Reis D, Gazzinelli A, Silva C, Gazzinelli M. Educação em saúde e representações sociais: uma experiencia no controle da leishmaniose tegumentar em área endémica de Minas Gerais, Brasil. Cad Saude Publica. 2006; 22:2301-2310.

Bernardes Filho F, Queiroz RM, Nery B. American Tegumentary Leishmaniasis. J Emerg Med. 2018; 54(5):692-693. (doi: 10.1016/j.jemermed.2018.02.003).

Isaza D, Restrepo B, Arboleda M. La leishmaniasis: conocimientos y prácticas en poblaciones de la costa del Pacífico de Colombia. Rev Panam Salud Publica. 2000 6(3):177-184.

Loiseau R, Nabet C, Simon S, Ginouves M, Brousse P, Blanchet D, Demar M, Couppie P, Blaizot R. American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors. Int J Dermatol. 2019; 58(11):1323-1328. (doi: 10.1111/ijd.14625).

Fajardo P, Monje C, Lozano G, Realpe O, Hernández L. Nociones populares sobre “Dengue” y “Rompehuesos”, dos modelos de la enfermedad en Colombia. Rev Panam Salud Publica. 2001; 10(3):161-168.

Tabbabi A. Review of Leishmaniasis in the Middle East and North Africa. Afri Health Sci. 2019; 19(1):1329-1337. (doi: 10.4314/ahs.v19i1.4).

Garapati P, Pal B, Siddiqui NA, Bimal S, Das P, Murti K, Pandey K. Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India. PLoS One. 2018; 13(9):e0203407. (doi: 10.1371/journal.pone.0203407).

Published
2020-01-08
How to Cite
1.
Abdel K, Hernández D, Hidalgo O, Hidalgo S, Lorenzo C, Hung F, Bastidas G. Clinical-epidemiological characteristics and knowledge on american tegumentary leishmaniosis in a Carabobo state population. Venezuela. Rev Peru Investig Salud [Internet]. 8Jan.2020 [cited 25Sep.2020];4(1):09-6. Available from: http://revistas.unheval.edu.pe/index.php/repis/article/view/478
Section
Artículos originales